MENINGITIS VACCINE MARKET 2018 - 2025 Details - Latest Trend and Projections for The Coming Years with Trends and Opportunities

Press Release - 05 July 2018
Research and Development News --
. .
Latest Update "Meningitis Vaccine Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2017 - 2025" with Industries Survey | Global Current Growth and Future.
' '
Meningitis is an inflammation (swelling) of the defensive layers called meninges covering the brain and spinal cord. A bacterial or viral contamination of the fluid encompassing the brain and spinal cord ordinarily causes the swelling. However, wounds, disease, certain medications, and different kinds of infections can also cause meningitis.

Bacterial meningitis is intense and can be mortal. Additionally, bacterial meningitis can cause permanent disabilities such as brain damage and hearing loss, if untreated. However, the vast majority of meningitis can prevent with proper vaccination. Streptococcus pneumonia, neisseria meningitides, and listeria monocytogenes are some classes of bacteria that cause meningitis. Nausea, vomiting, photophobia, and altered mental status are some symptoms of meningitis. Immunization can help to prevent bacterial meningitis.
. .
– Get Sample Report_https://www.researchmoz.us/enquiry.php?type=S&repid=1825173
' '
Based on vaccine type, the global meningitis vaccine market can be segmented into haemophilus influenza type b vaccine, pneumococcal conjugate vaccine, pneumococcal polysaccharide vaccine, meningococcal vaccine, and others. The meningococcal vaccine segment is likely to expand at a significant pace during the forecast period because meningococcal vaccine can protect from four classes of bacteria that cause meningitis. The meningococcal vaccine segment can be sub-classified into meningococcal conjugate vaccines and serogroup B meningococcal vaccines.

In terms of end-user, meningitis vaccine market can be bifurcated into adults and children. The children segment is expected to grow at a faster rate because bacterial meningitis mostly affects children. In terms of distribution channel, the global meningitis vaccine market can be segmented into hospital pharmacies, retail pharmacies, and others. The hospital pharmacies segment is likely to expand at a significant pace during the forecast period as several types of vaccine are widely available in hospital pharmacies. 

Increase in incidence of meningitis in children is one of the major factors fueling the global meningitis vaccine market. Moreover, risk of permanent disabilities among children and rise in awareness about proper dose of immunization is projected to drive the meningitis vaccine market. However, bacterial resistance to penicillin and lack of access to vaccine approval are likely to hamper meningitis vaccine market in the next few years.

In terms of region, the global meningitis vaccine market can be segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America dominates the global meningitis vaccine market. The region is projected to account for a significant share of the global meningitis vaccine market during the forecast period due to presence of key vaccine manufacturers and awareness about immunization. Favorable government support in terms of inclusion of vaccination such as meningococcal C conjugate (MCC) vaccine in national routine immunization schedules by the European Center for Disease Prevention and Control to treat meningitis is likely to drive the meningitis vaccine market in Europe. Incidence of bacterial meningitis is increasing in countries such as Thailand and North Korea. This drives demand for vaccination to combat the disease which in turn is expected to propel meningitis vaccine market in Asia Pacific. Increase in awareness about meningitis immunization and high prevalence of bacterial meningitis are likely to augment the meningitis vaccine market in Middle East & Africa during the forecast period.

Key players operating in the global meningitis vaccine market are GlaxoSmithKline, plc, Pfizer, Inc., Merck & Co., Inc., Sanofi Pasteur SA, Astellas Pharma Inc., CSL Limited, Emergent BioSolutions, Inc., Johnson & Johnson, MedImmune, LLC, Serum Institute of India Pvt. Ltd., Bavarian Nordic, Mitsubishi Tanabe Pharma Corporation, Protein Sciences Corporation, and Panacea Biotec, among others.

The report offers a comprehensive evaluation of the market. It does so via in-depth qualitative insights, historical data, and verifiable projections about market size. The projections featured in the report have been derived using proven research methodologies and assumptions. By doing so, the research report serves as a repository of analysis and information for every facet of the market, including but not limited to: Regional markets, technology, types, and applications.

- The study is a source of reliable data on:

Market segments and sub-segments
Market trends and dynamics
Supply and demand
Market size
Current trends/opportunities/challenges
Competitive landscape
Technological breakthroughs
Value chain and stakeholder analysis

- The regional analysis covers:

North America (U.S. and Canada)
Latin America (Mexico, Brazil, Peru, Chile, and others)
Western Europe (Germany, U.K., France, Spain, Italy, Nordic countries, Belgium, Netherlands, and Luxembourg)
Eastern Europe (Poland and Russia)
Asia Pacific (China, India, Japan, ASEAN, Australia, and New Zealand)
Middle East and Africa (GCC, Southern Africa, and North Africa)

The report has been compiled through extensive primary research (through interviews, surveys, and observations of seasoned analysts) and secondary research (which entails reputable paid sources, trade journals, and industry body databases). The report also features a complete qualitative and quantitative assessment by analyzing data gathered from industry analysts and market participants across key points in the industry’s value chain.

A separate analysis of prevailing trends in the parent market, macro- and micro-economic indicators, and regulations and mandates is included under the purview of the study. By doing so, the report projects the attractiveness of each major segment over the forecast period.
. .
– More Clear Details get Table of Contents_https://www.researchmoz.us/meningitis-vaccine-market-global-industry-analysis-size-share-growth-trends-and-forecast-2017-2025-report.html#table-of-content
' '
- Highlights of the report:

A complete backdrop analysis, which includes an assessment of the parent market
Important changes in market dynamics
Market segmentation up to the second or third level
Historical, current, and projected size of the market from the standpoint of both value and volume

Continue.....

ResearchMoz is the world’s fastest growing collection of market research reports worldwide. Our database is composed of current market studies from over 100 featured publishers worldwide. Our market research databases integrate statistics with analysis from global, regional, country and company perspectives. ResearchMoz’s service portfolio also includes value-added services such as market research customization, competitive landscaping, and in-depth surveys, delivered by a team of experienced Research Coordinators.

Researchmoz Global Pvt. Ltd.
90 State Street,
Albany, NY 12207,
United States,
Tel: 866-997-4948 (Us-Canada Toll Free),
Tel: +1-518-621-2074

This release was published on openPR.